Robert Cerwinski is a seasoned and highly effective intellectual property litigator. For more than a decade, he has successfully represented both plaintiffs and defendants in patent and trade secret litigation before federal and state courts across the country. His primary focus is on litigation involving pharmaceutical and biological products.
Mr. Cerwinski brings to his practice an exceptional combination of patent law expertise and technical proficiency in the pharmaceutical and biotechnology fields. Recently, he helped his client Teva Pharmaceuticals, the world’s leading maker of generic drugs, favorably resolve a long-running ANDA litigation against Pfizer concerning Teva’s AB-rated generic equivalent to Pfizer’s Neurontin® product. The settlement ending this case was reached just two weeks into a jury trial that had been scheduled to last seven weeks.
Mr. Cerwinski holds a graduate degree in cellular and molecular biology. Before pursuing a career in law, Mr. Cerwinski worked for a major Japanese pharmaceutical company in Tokyo assisting with the prosecution of patents for biotechnology products.
bar and court admissions
U.S. District Court for the Southern District of New York
U.S. District Court for the Eastern District of New York
New York State Bar Association, Committee on Patents of the Association of the Bar of the City of New York, American Intellectual Property Law Association, New York Intellectual Property Law Association